Anyone going through fertility treatments has wondered just what their chances for success might be. Well wonder no more. The Society for Assisted Reproductive Technology (SART), has just released the SART ART Success Predictor, version 1.0 – a very helpful IVF predictor tool in informing patients their odds for a successful treatment.
This version presents 3 outcomes based on patient age, parity, height/weight, and diagnoses:
- The chance of a liveborn after 1, 2, and 3 fresh IVF tries
- The chance of a liveborn with self versus donor eggs
- The chance of a liveborn and multiple pregnancy when doing two eSETs versus one DET.
These calculations are based on SART data collected since 2006, which includes more than 500,000 cycles in over 320,000 patients. SART funded the research that developed these IVF predictor models, and will update them over time.
SART’s new Patient Predictor Tool is free to use and may be found by clicking here.
Although the current tool has limits (it doesn’t include outcomes from frozen embryos, nor distinguish day 3 from day 5 transfers) it gives patients a “ball park” figure to try to understand their chances.
Learn more about GENESIS Fertility’s New York IVF program.
If you would like to learn more about GENESIS Fertility New York or are ready to schedule an appointment, please speak with one of our representatives at 718-GENESIS.
